Scientific Board Prof. Dr. Stefan Kochanek, former group leader at the Center for Molecular Medicin in Cologne is now the Director of the Division of Gene Therapy at the University of Ulm. He is an internationally well known expert in gene therapy and vector development Prof. Dr. Bernd Kirchhoff is Director of the Department of Vitreoretinal Surgery at the University of Cologne. He is a leading expert in the treatment of age related macular degeneration and other ocular diseases. Prof. Dr. Volker Sturm is Director of the Department of Stereotaxy and Functional Neurosurgery at the University of Cologne. His department has a leading role in surgical treatment of patients with Parkinson's Disease and chronic pain. Prof. Dr. Ulrich Schraermeyer is Director of the Division of Experimental Vitreoretinal Surgery at the University of Tübingen. He is an expert in the function of the iris and the pigmentary epithelium.

   Using CEVEC's proprietary technology, primary human amniocytes have been immortalized by adenoviral genetic E1/pIX functions and selected for highly efficient CAP (CEVEC's Amniocyte Production) Cell Lines. CAP (CEVEC's Amniocyte Production) Cell Lines contain adenovirus type 5 nucleotide sequence 505-4079 including the E1 genes and the entire pIX sequence.